| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.068 | 0.2 |